MILAN — The European Respiratory Society (ERS) Congress 2023 dedicated an entire session to the multifaceted challenges and ongoing debates surrounding progressive pulmonary fibrosis (PPF). Renowned ...

Please provide your email address to receive an email when new articles are posted on . Annual incidence of asymptomatic pulmonary fibrosis in relatives of those with familial interstitial pneumonia ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Machine learning model accurately diagnoses interstitial pneumonia, matching pulmonologist expertise and predicting mortality ...

Yale researchers have identified a potential treatment for idiopathic pulmonary fibrosis, or IPF, which can reverse lung scarring. In a study recently published in “JCI Insight,” researchers from the ...

VIENNA — Treatment with a novel lysophosphatidic acid receptor 1 (LPA1) antagonist was associated with significant changes in baseline biomarkers of disease in adults with pulmonary fibrosis, based on ...

A research group from the National Cancer Research Center (CNIO) has found that an alteration in the POT1 gene prevents lung tissue from regenerating, which over time makes breathing difficult. The ...